Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

A Blood Test That Predicts Heart Disease

MP3 WAV

  • Ben Franklin is credited with saying that only two things in life are inevitable - death and taxes. Practically speaking, you can always file an extension with the IRS to delay your taxes. Wouldn't it be nice to be able to do the same with some of the leading causes of death? A new research diagnostic advance may make this a reality someday soon.

    Two of the leading causes of death among Americans are heart disease and strokes. According to 2020 data from the CDC, heart disease was the leading cause of death at almost 700,000 reported deaths, and stroke was the fifth leading cause of death, with more than 160,000.

    A new blood test developed by the biomedical technology company SomaLogic in Boulder, Colorado, focuses on proteins in the blood that could provide an early warning for heart disease and stroke patients. Existing risk models for heart and cardiovascular diseases are based on cholesterol levels, genetics, medical history, race, age, sex and blood pressure. While these have been helpful, further improvements would help save lives.

    The research analyzed 5,000 proteins present in blood plasma. Plasma is the yellowish liquid component of your blood. The scientists analyzed plasma from almost 23,000 people to search for proteins that would allow a 4-year prediction of heart disease, heart attack, heart failure or stroke. To do this, the scientists used a specially programmed computer to look for patterns in the huge volume of data. There is truly power in numbers!

    Their results identified 27 proteins that provided a molecular signature for future heart disease and stroke risk. A molecular signature is a pattern of molecules, proteins in this case, that point to a certain outcome. Because of the way proteins interact with cells in the rest of the body, we can use a molecular signature to predict a future outcome, almost like the ingredients in a recipe. These 27 proteins were part of ten different biochemical pathways in cells and 12 of them were related to known genetic traits associated with heart disease and/or stroke.

    This new risk model allows individuals to be characterized from a low to high risk. High scores predict a 50% chance of an incident over the next 18 months and possibly death. This provides a clear warning to patients and their physicians for future possibility of serious disease consequences. This early warning could be a life saver to begin medical treatments, lifestyle changes and/or drugs to lower the chances of a severe event. The model worked for those that had a previous stroke or heart attack, which is an improvement over existing risk models, which do not perform well in this group of patients.

    The patients' protein patterns changed as their disease risk changed, making this test valuable for following the effectiveness of treatments and medications. This test could also be used to evaluate new drug clinical trials or other interventions. This could be an important new tool that will save people's lives. We will watch the development of this new diagnostic closely.

More Information

A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk
A reliable, individualized, and dynamic surrogate of cardiovascular risk, synoptic for key biologic mechanisms, could shorten the path for drug development, enhance drug cost-effectiveness and improve patient outcomes...

New blood test predicts risk of heart attack and stroke with twice previous accuracy
New technique, already available in US, could aid in development of cardiovascular drugs...

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

See all podcasts and radio stations

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.